Triple therapy may turn inoperable stomach cancer into surgical candidates

NCT ID NCT07072351

First seen Jan 11, 2026 · Last updated May 09, 2026 · Updated 14 times

Summary

This study is for people with advanced gastroesophageal junction cancer that cannot be removed with surgery. It tests a combination of targeted radiation, immunotherapy, and chemotherapy to shrink the tumor enough so that surgery becomes possible. About 88 adults will take part to see if this approach is safe and effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Seventh People's Hospital of Chengdu

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • West China Shangjin Nanfu Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • West China Xiamen Hospital, Sichuan University

    RECRUITING

    Xiamen, Fujian, China

Conditions

Explore the condition pages connected to this study.